Lilly Humalog European Labeling Adds HbA1c Lowering Claim

Revised EU labeling for Lilly's Humalog (insulin lispro) includes a claim that the insulin analog reduces hemoglobin A1c more effectively than soluble insulin when administered in subcutaneous infusion pumps.